We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





Ultrasound Waves at Medical Imaging Frequencies Can Damage SARS-CoV-2 and Could Treat COVID-19

By HospiMedica International staff writers
Posted on 19 Mar 2021
Simulations have shown that ultrasound waves at medical imaging frequencies can cause the shell and spikes of the SARS-CoV-2 virus to collapse and rupture, suggesting the possibility of ultrasound-based treatment for COVID-19.

A new study by researchers in MIT’s Department of Mechanical Engineering (Cambridge, MA, USA) suggests that coronaviruses may be vulnerable to ultrasound vibrations, within the frequencies used in medical diagnostic imaging. More...
Through computer simulations, the team has modeled the virus’ mechanical response to vibrations across a range of ultrasound frequencies. They found that vibrations between 25 and 100 megahertz triggered the virus’ shell and spikes to collapse and start to rupture within a fraction of a millisecond. This effect was seen in simulations of the virus in air and in water.

The results are preliminary, and based on limited data regarding the virus’ physical properties. Nevertheless, the researchers say their findings are a first hint at a possible ultrasound-based treatment for coronaviruses, including the novel SARS-CoV-2 virus. How exactly ultrasound could be administered, and how effective it would be in damaging the virus within the complexity of the human body, are among the major questions scientists will have to tackle going forward.

To refine and validate their simulations, the team is working with microbiologists in Spain, who are using atomic force microscopy to observe the effects of ultrasound vibrations on a type of coronavirus found exclusively in pigs. If ultrasound can be experimentally proven to damage coronaviruses, including SARS-CoV-2, and if this damage can be shown to have a therapeutic effect, the team envisions that ultrasound, which is already used to break up kidney stones and to release drugs via liposomes, might be harnessed to treat and possibly prevent coronavirus infection. The researchers also envision that miniature ultrasound transducers, fitted into phones and other portable devices, might be capable of shielding people from the virus.

“We’ve proven that under ultrasound excitation the coronavirus shell and spikes will vibrate, and the amplitude of that vibration will be very large, producing strains that could break certain parts of the virus, doing visible damage to the outer shell and possibly invisible damage to the RNA inside,” said Tomasz Wierzbicki, professor of applied mechanics at MIT. “We looked at the general coronavirus family, and now are looking specifically at the morphology and geometry of COVID-19. The potential is something that could be great in the current critical situation.”

Related Links:
Massachusetts Institute of Technology (MIT)


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
IV Therapy Cart
Avalo I.V Therapy Cart
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.